|
2024
|
Invention
|
Therapies with lanthionine c-like protein 2 ligands and cells prepared therewith.
Provided are c... |
|
|
Invention
|
Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same.
Provid... |
|
2022
|
Invention
|
Lanthionine synthetase c-like 2-based therapeutics.
Provided are compounds that target the lanth... |
|
|
Invention
|
Crystalline forms of piperazine-1,4-diylbis((6-(1h-benzo[d]imidazo-2-yl)pyridin-2yl)methanone). C... |
|
|
Invention
|
Lancl ligands. Provided are compounds of Formula (I):
The compounds target the lanthionine s... |
|
|
Invention
|
Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same. Provide... |
|
2021
|
Invention
|
Compounds, compositions, and methods for treating inflammatory or immune-mediated conditions of s... |
|
|
Invention
|
Therapies with lanthionine c-like protein 2 ligands and cells prepared therewith. Provided are co... |
|
|
Invention
|
Crystalline forms of piperazine-1,4-diylbis((6-(1h-benzoi[d]imidazo-2-yl)pyridin-2yl)methanone) a... |
|
|
Invention
|
Lancl ligands. Provided are compounds that target the lanthionine synthetase C-like (LANCL) famil... |
|
2020
|
Invention
|
Lanthionine synthetase c-like 2-based therapeutics. Provided are compounds that target the lanthi... |
|
2015
|
Invention
|
Lanthionine synthetase c-like 2-based therapeutics.
Herein are provided compounds that... |
